225Ac

You have access
Efficacy of HER2-Targeted Intraperitoneal ²²⁵Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
Sebastian K. Chung, Daniela Burnes Vargas, Christopher S. Chandler, Sumudu Katugampola, Darren R. Veach, Michael R. McDevitt, Shin H. Seo, Brett A. Vaughn, Sara S. Rinne, Blesida Punzalan, Mitesh Patel, Hong Xu, Hong-Fen Guo, Pat B. Zanzonico, Sébastien Monette, Guangbin Yang, Ouathek Ouerfelli, Garrett M. Nash, Andrea Cercek, Edward K. Fung, Roger W. Howell, Steven M. Larson, Sarah M. Cheal and Nai-Kong V. Cheung

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1439-1445; DOI: https://doi.org/10.2967/jnumed.122.265095
Open Access
Evaluation of ¹³⁴Ce/¹³⁴La as a PET Imaging Theranostic Pair for ²²⁵Ac α-Radiotherapeutics
Kondapa Naidu Bobba, Anil P. Bidkar, Niranjan Meher, Cyril Fong, Anju Wadhwa, Suchi Dhrona, Alex Sorlin, Scott Bidlingmaier, Becka Shuere, Jiang He, David M. Wilson, Bin Liu, Youngho Seo, Henry F. VanBrocklin and Robert R. Flavell

Journal of Nuclear Medicine July 1, 2023, 64 (7) 1076-1082; DOI: https://doi.org/10.2967/jnumed.122.265355
Open Access
Signaling Network Response to α-Particle–Targeted Therapy with the ²²⁵Ac-Labeled Minigastrin Analog ²²⁵Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors
Yun Qin, Stefan Imobersteg, Stephan Frank, Alain Blanc, Tanja Chiorazzo, Philipp Berger, Roger Schibli, Martin P. Béhé and Michal Grzmil

Journal of Nuclear Medicine June 1, 2023, 64 (6) 873-879; DOI: https://doi.org/10.2967/jnumed.122.264597
Open Access
Cure of Disseminated Human Lymphoma with [²²⁵Ac]Ac-Ofatumumab in a Preclinical Model
Mark S. Longtine, Kyuhwan Shim, Mark J. Hoegger, Nadia Benabdallah, Diane S. Abou, Daniel L.J. Thorek and Richard L. Wahl

Journal of Nuclear Medicine June 1, 2023, 64 (6) 924-931; DOI: https://doi.org/10.2967/jnumed.122.265167
You have access
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, Alfred Morgenstern, Matthias Eiber, Ken Herrmann and Kelsey L. Pomykala

Journal of Nuclear Medicine May 1, 2023, 64 (5) 685-692; DOI: https://doi.org/10.2967/jnumed.122.265353
You have access
Combination of Carriers with Complementary Intratumoral Microdistributions of Delivered α-Particles May Realize the Promise for ²²⁵Ac in Large, Solid Tumors
Alaina Howe, Omkar Bhatavdekar, Dominick Salerno, Anders Josefsson, Jesus Pacheco-Torres, Zaver M. Bhujwalla, Kathleen L. Gabrielson, George Sgouros and Stavroula Sofou

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1223-1230; DOI: https://doi.org/10.2967/jnumed.121.262992
You have access
Effects of ²²⁵Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
Dong Yun Lee and Yong-il Kim

Journal of Nuclear Medicine June 1, 2022, 63 (6) 840-846; DOI: https://doi.org/10.2967/jnumed.121.262017
Open Access
First In Vivo and Phantom Imaging of Cyclotron-Produced ¹³³La as a Theranostic Radionuclide for ²²⁵Ac and ¹³⁵La
Bryce J.B. Nelson, Simon Ferguson, Melinda Wuest, John Wilson, M. John M. Duke, Susan Richter, Hans Soenke-Jans, Jan D. Andersson, Freimut Juengling and Frank Wuest

Journal of Nuclear Medicine April 1, 2022, 63 (4) 584-590; DOI: https://doi.org/10.2967/jnumed.121.262459
You have access
TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using ²²⁵Ac-Labeled DOTAylated-huCC49 Antibody
Megan Minnix, Lin Li, Paul J. Yazaki, Aaron D. Miller, Junie Chea, Erasmus Poku, An Liu, Jeffrey Y.C. Wong, Russell C. Rockne, David Colcher and John E. Shively

Journal of Nuclear Medicine January 1, 2021, 62 (1) 55-61; DOI: https://doi.org/10.2967/jnumed.120.243394
You have access
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes
Clemens Kratochwil, Frederik L. Giesel, Claus-Peter Heussel, Daniel Kazdal, Volker Endris, Cathleen Nientiedt, Frank Bruchertseifer, Maximilian Kippenberger, Hendrik Rathke, Jonas Leichsenring, Markus Hohenfellner, Alfred Morgenstern, Uwe Haberkorn, Stefan Duensing and Albrecht Stenzinger

Journal of Nuclear Medicine May 1, 2020, 61 (5) 683-688; DOI: https://doi.org/10.2967/jnumed.119.234559

Main menu

User menu

Search

225Ac

Pages